The present invention relates to methods and compositions for the treatment and the prevention of {TAIL ~ eye disorders} related to high levels of expression or activity of 11beta {HEAD ~ hydroxysteroid} dehydrogenase 1 ; in particular but not exclusively to the treatment of glaucoma 
The present invention relates to methods and compositions for the treatment and the prevention of { TAIL ~ eye disorders } related to high levels of expression or activity of 11beta { HEAD ~ hydroxysteroid } dehydrogenase 1 ; in particular but not exclusively to the treatment of glaucoma
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH